Pfizer

Vaccine Contracts BioNTech Acquisitions Contracts Revenue Sales COVID-19 Vaccine Financial Performance COVID-19 Products CEO Albert Bourla Albert Bourla Financial Outlook Quarterly Losses COVID-19 Treatment Clinical Trials Vaccine Negotiations Vaccine Development Corporate Governance Marketing Practices COVID-19 Vaccines

19 ARTICLES

last mo.

EU Court Overturns Commission's Refusal to Release von der Leyen-Pfizer Texts

The General Court annulled the European Commission's decision, citing insufficient justification for withholding the messages, and ordered a fresh review of the FOI request.

9 ARTICLES

last mo.

Pfizer Posts $2.38 Billion Q3 Loss Amid Sharp Drop in Covid Vaccine and Paxlovid Revenue

Pfizer

EU Court Overturns Commission's Refusal to Release von der Leyen-Pfizer Texts

EU Court Overturns Commission’s Refusal to Release von der Leyen-Pfizer SMS

EU Tribunal Rules Commission Wrongfully Withheld Vaccine SMS

EU Court Orders Disclosure of Von der Leyen's Pfizer Texts

Kansas Sues Pfizer Over Misleading COVID-19 Vaccine Claims

Pfizer's Lorbrena Sets New Benchmark in Treating Advanced Lung Cancer

Pfizer Shares Hit 10-Year Low Amid Decreased Demand for COVID-19 Products

Pfizer Posts $2.38 Billion Q3 Loss Amid Sharp Drop in Covid Vaccine and Paxlovid Revenue